Accéder au contenu
Merck

The structural intolerance of the PrP alpha-fold for polar substitution of the helix-3 methionines.

Cellular and molecular life sciences : CMLS (2010-05-11)
Silvia Lisa, Massimiliano Meli, Gema Cabello, Ruth Gabizon, Giorgio Colombo, María Gasset
RÉSUMÉ

The conversion of the cellular prion protein (PrP(C)) into its disease-associated form (PrP(Sc)) involves a major conformational change and the accumulation of sulfoxidized methionines. Computational and synthetic approaches have shown that this change in the polarity of M206 and M213 impacts the C-terminal domain native alpha-fold allowing the flexibility required for the structural conversion. To test the effect in the full-length molecule with site-specificity, we have generated M-to-S mutations. Molecular dynamics simulations show that the replacement indeed perturbs the native state. When this mutation is placed at the conserved methionines of HaPrP(23-231), only substitutions at the Helix-3 impair the alpha-fold, stabilizing a non-native state with perturbed secondary structure, loss of native tertiary contacts, increased surface hydrophobicity, reduced thermal stability and an enhanced tendency to aggregate into protofibrillar polymers. Our work supports that M206 and M213 function as alpha-fold gatekeepers and suggests that their redox state regulate misfolding routes.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
L-Norleucine, ≥98% (TLC)
Sigma-Aldrich
L-Norleucine, suitable for amino acid analysis, BioReagent